Science Explorer Back to mapMap
Discussion
Hospital / health system · Birmingham · United States

Alabama Clincal Therapeutics

Research works
2
▼ 29% vs 2018-21
Citations
62
28.6 per fractional work
Top-10% rate
40.9%
all institutions 10.0%
Open access
93%
world 40%
International
21%
world 18%

Not ranked overall: Alabama Clincal Therapeutics is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Alabama Clincal Therapeutics work in?

In all years, 68% of research at Alabama Clincal Therapeutics is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (59%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (9%). It does 1.3× the world's share of Health Sciences.

Life Sciences32%Health Sciences68%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 6 fields, with their numbers
    1. Medicine159.1%
    2. Health Professions04.5%
    3. Nursing04.5%
    1. Biochemistry, Genetics and Molecular Biology018.2%
    2. Immunology and Microbiology09.1%
    3. Agricultural and Biological Sciences04.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Alabama Clincal Therapeutics?

The most cited paper from Alabama Clincal Therapeutics is "Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures: The EVOLVE Trial" (Douglas P. Beall, Melissa R. Chambers, Sam Thomas et al., 2018), with 68 citations. Next come "Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial" (67) and "Reexamination of Pharmacokinetics of Oral Testosterone Undecanoate in Hypogonadal Men With a New Self‐Emulsifying Formulation" (52).

Most cited papers
#PaperReleasedCitations
1 Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures: The EVOLVE Trial Douglas P. Beall, Melissa R. Chambers, Sam Thomas et al. · Neurosurgery Open access 18 Jan 2018 68
2 Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial Claude Ashley, W. H. Johnston, Cheryl L. Harris et al. · Nutrition Journal Open access 7 Jun 2012 67
3 Reexamination of Pharmacokinetics of Oral Testosterone Undecanoate in Hypogonadal Men With a New Self‐Emulsifying Formulation Anthony Yin, Michelle Htun, Ronald S. Swerdloff et al. · Journal of Andrology Open access 26 Jan 2012 52
4 A Randomized Clinical Trial to Evaluate Two Doses of an Intra-Articular Injection of LMWF-5A in Adults with Pain Due to Osteoarthritis of the Knee David Bar‐Or, Kristin Salottolo, Holli Loose et al. · PLoS ONE Open access 3 Feb 2014 48
5 Six-Month Outcomes of Mechanical Thrombectomy for Treating Deep Vein Thrombosis: Analysis from the 500-Patient CLOUT Registry Abdullah A. Shaikh et al. · CardioVascular and Interventional Radiology Open access 14 Aug 2023 41
All 15 most cited papers, with filters and sorting

Which research topics does Alabama Clincal Therapeutics publish most on?

By volume in 2022-now: Cancer Immunotherapy and Biomarkers, Cancer Research and Treatments, Virus-based gene therapy research and Global Cancer Incidence and Screening.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 0 works
  2. 2 Cancer Research and Treatments Biotechnology 0 works
  3. 3 Virus-based gene therapy research Genetics 0 works
  4. 4 Global Cancer Incidence and Screening Oncology 0 works
  5. 5 Reproductive tract infections research Microbiology 0 works
  6. 6 Cervical Cancer and HPV Research Epidemiology 0 works
  7. 7 Tendon Structure and Treatment Orthopedics and Sports Medicine 0 works
  8. 8 Periodontal Regeneration and Treatments Urology 0 works
  9. 9 Neonatal skin health care Speech and Hearing 0 works
  10. 10 Infant Health and Development Pharmacy 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available93.4%not open6.6%

World: 40% of research is openly available.

with international co-authors21.4%domestic only78.6%

World: 18% is written across borders.

How has Alabama Clincal Therapeutics's research output changed?

Output in 2022-2025 was 29% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Birmingham

All research institutions in Birmingham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Alabama Clincal Therapeutics. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.